Cargando…
Molecular remission using three monoclonal antibodies followed by allogeneic bone marrow transplantation in an infant with refractory ALL
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8277651/ https://www.ncbi.nlm.nih.gov/pubmed/32067128 http://dx.doi.org/10.1007/s00277-020-03957-z |
| _version_ | 1783722119008354304 |
|---|---|
| author | Gruhn, Bernd Brodt, Grit Wittig, Susan Ernst, Thomas Ernst, Jana |
| author_facet | Gruhn, Bernd Brodt, Grit Wittig, Susan Ernst, Thomas Ernst, Jana |
| author_sort | Gruhn, Bernd |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8277651 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-82776512021-07-20 Molecular remission using three monoclonal antibodies followed by allogeneic bone marrow transplantation in an infant with refractory ALL Gruhn, Bernd Brodt, Grit Wittig, Susan Ernst, Thomas Ernst, Jana Ann Hematol Letter to the Editor Springer Berlin Heidelberg 2020-02-18 2020 /pmc/articles/PMC8277651/ /pubmed/32067128 http://dx.doi.org/10.1007/s00277-020-03957-z Text en © The Author(s) 2020, corrected publication 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Letter to the Editor Gruhn, Bernd Brodt, Grit Wittig, Susan Ernst, Thomas Ernst, Jana Molecular remission using three monoclonal antibodies followed by allogeneic bone marrow transplantation in an infant with refractory ALL |
| title | Molecular remission using three monoclonal antibodies followed by allogeneic bone marrow transplantation in an infant with refractory ALL |
| title_full | Molecular remission using three monoclonal antibodies followed by allogeneic bone marrow transplantation in an infant with refractory ALL |
| title_fullStr | Molecular remission using three monoclonal antibodies followed by allogeneic bone marrow transplantation in an infant with refractory ALL |
| title_full_unstemmed | Molecular remission using three monoclonal antibodies followed by allogeneic bone marrow transplantation in an infant with refractory ALL |
| title_short | Molecular remission using three monoclonal antibodies followed by allogeneic bone marrow transplantation in an infant with refractory ALL |
| title_sort | molecular remission using three monoclonal antibodies followed by allogeneic bone marrow transplantation in an infant with refractory all |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8277651/ https://www.ncbi.nlm.nih.gov/pubmed/32067128 http://dx.doi.org/10.1007/s00277-020-03957-z |
| work_keys_str_mv | AT gruhnbernd molecularremissionusingthreemonoclonalantibodiesfollowedbyallogeneicbonemarrowtransplantationinaninfantwithrefractoryall AT brodtgrit molecularremissionusingthreemonoclonalantibodiesfollowedbyallogeneicbonemarrowtransplantationinaninfantwithrefractoryall AT wittigsusan molecularremissionusingthreemonoclonalantibodiesfollowedbyallogeneicbonemarrowtransplantationinaninfantwithrefractoryall AT ernstthomas molecularremissionusingthreemonoclonalantibodiesfollowedbyallogeneicbonemarrowtransplantationinaninfantwithrefractoryall AT ernstjana molecularremissionusingthreemonoclonalantibodiesfollowedbyallogeneicbonemarrowtransplantationinaninfantwithrefractoryall |